本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Unicycive Therapeutics, Inc.

0.6101
+0.00981.63%
盤後0.62900.0189+3.10%19:39 EDT
成交量:83.19萬
成交額:51.18萬
市值:7,303.20萬
市盈率:-1.08
高:0.6318
開:0.6300
低:0.5920
收:0.6003
資料載入中...
2025/04/14

重要事件披露

Form 8-K/A - Current report: [Amend]
2025/04/02

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/04/01

重要事件披露

Form 8-K - Current report
2025/03/31

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/07

重要事件披露

Form 8-K - Current report
2024/11/19

SEC問詢函

Form CORRESP - Correspondence
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/13

重要事件披露

Form 8-K - Current report
2024/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/10/11

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/25

重要事件披露

Form 8-K - Current report
2024/08/14

重要事件披露

Form 8-K - Current report
2024/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/19

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors